The National Center for Advancing Translational Sciences has awarded Johns Hopkins University School of Medicine, Oregon Health & Science University, Northwestern University and others a five-year, $25 million agreement to develop the CD2H.
The consortium will use induced pluripotent stem cell (iPSC) technology — a type of stem cell that can be generated from adult stem cells — to find better treatments for the two psychiatric conditions.
These strategies and practices can significantly shorten the life cycle of claims, leading to quicker resolutions and improved financial outcomes.
We all know that certain behaviors like smoking, spending too much time in the sun, drinking excessively or an unhealthy diet can put us at risk for developing cancer. But according to some new research published in Science, unlucky, random cell mutation is the reason behind two thirds of cancer cases. Cristian Tomasetti and Bert […]